LEAH FOSTER: Open Payments
NPI 1689451411 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 16 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $56 |
| Lilly USA, LLC | 2 | $39 |
| Dexcom, Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| Astellas Pharma US Inc | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Corium, LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: Dexcom G6 Transmitter, Veozah, REXULTI, Rybelsus, ENTRESTO, ZEPBOUND, MOUNJARO, Ozempic.
Industry payments across IN — which companies pay providers there.
